Key result
Statin use was associated with a 15% decrease in D-dimer levels in patients with suspected pulmonary embolism, whereas antiplatelet use had no significant effect.
Why the study?
Does concomitant use of statins or antiplatelet drugs affect D-dimer levels and diagnostic accuracy in patients with suspected pulmonary embolism?
Observational (n=1,029)
Does concomitant use of statins or antiplatelet drugs affect D-dimer levels and diagnostic accuracy in patients with suspected pulmonary embolism?
While statin use modestly decreases D-dimer levels in patients with suspected pulmonary embolism, adjusting diagnostic cut-offs for statin use does not improve diagnostic safety or accuracy.
Answers are grounded in this paper and cite their sources.
Statin-related D-dimer changes should not prompt threshold adjustment in suspected PE; this observational analysis leaves open effects on diagnostic strategies.
BACKGROUND: Acute pulmonary embolism may be ruled out by combining nonhigh clinical probability and a normal D-dimer level. Both antiplatelet drugs and HMG-CoA reductase inhibitors (statins) have been associated with effects on thrombus formation, potentially influencing D-dimer levels in this setting, leading to a higher rate of false-negative tests. Therefore, we determined whether D-dimer levels in patients with suspected pulmonary embolism are affected by concomitant use of antiplatelet drugs and/or statins and evaluated whether the effect of antiplatelet drugs or statins might affect diagnostic accuracy. MATERIALS AND METHODS: We performed a posthoc analysis in the YEARS diagnostic study, comparing age- and sex-adjusted D-dimer levels among users of antiplatelet drugs, statins and nonusers. We then reclassified patients within the YEARS algorithm by developing a model in which we adjusted D-dimer cut-offs for statin use and evaluated diagnostic accuracy. RESULTS: We included 156 statins users, 147 antiplatelet drugs users and 726 nonusers of either drugs, all with suspected pulmonary embolism. Use of antiplatelet drugs did not have a significant effect, whereas statin use was associated with 15% decrease in D-dimer levels (95% CI, -28% to -0.6%). An algorithm with lower D-dimer thresholds in statin users yielded lower specificity (0.42 compared to 0.33) with no difference in false-negative tests. CONCLUSIONS: We conclude that use of statins but not of antiplatelet agents is associated with a modest decrease in D-dimer levels. Adjusting D-dimer cut-offs for statin use did, however, not result in a safer diagnostic strategy in our cohort.
No takes yet. Share an insight, caveat, or question.
Schol‐Gelok et al. (2018) conducted an observational in Suspected pulmonary embolism (n=1,029). Statins and antiplatelet drugs vs. Nonusers was evaluated on Age- and sex-adjusted D-dimer levels (15% decrease, 95% CI -28% to -0.6%). Statin use was associated with a 15% decrease in D-dimer levels in patients with suspected pulmonary embolism, whereas antiplatelet use had no significant effect.
Synapse has enriched 10 related papers. Consider them for comparative context: